Replies to post #202068 on Biotech Values

[dewophile]

Would expect BMS to release a similar announcement quite soon for CheckMate 026 -- could be positive at a broader PD-L1 cutoff but remains to be seen.

BMY also has a combo arm w yervoy - could also be a differentiator from keytruda. That said others are looking at first line, many w combos - honestly it is hard to keep track